25 XP   0   0   10

Bioxyne Ltd
Buy, Hold or Sell?

Let's analyse Bioxyne together

PenkeI guess you are interested in Bioxyne Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bioxyne Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bioxyne Ltd

I send you an email if I find something interesting about Bioxyne Ltd.

Quick analysis of Bioxyne (30 sec.)










What can you expect buying and holding a share of Bioxyne? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.04
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.03
Return On Investment
404.3%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0 - A$0.009
How sure are you?
50%

1. Valuation of Bioxyne (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$-0.01 - A$0.00

Total Value Per Share

A$0.00 - A$0.01

2. Growth of Bioxyne (5 min.)




Is Bioxyne growing?

Current yearPrevious yearGrowGrow %
How rich?$9.7m-$239.1k$9.9m102.5%

How much money is Bioxyne making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$319.7k-$935.8k-74.5%
Net Profit Margin-37.6%-106.6%--

How much money comes from the company's main activities?

3. Financial Health of Bioxyne (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  

What can you expect buying and holding a share of Bioxyne? (5 min.)

Welcome investor! Bioxyne's management wants to use your money to grow the business. In return you get a share of Bioxyne.

What can you expect buying and holding a share of Bioxyne?

First you should know what it really means to hold a share of Bioxyne. And how you can make/lose money.

Speculation

The Price per Share of Bioxyne is A$0.008. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioxyne.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioxyne, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioxyne.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-8.4%0.00-8.4%0.00-1.0%0.00-3.9%0.00-2.1%
Usd Book Value Change Per Share0.0165.4%0.0165.4%0.00-9.8%0.009.1%0.006.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0165.4%0.0165.4%0.00-9.8%0.009.1%0.006.5%
Usd Price Per Share0.01-0.01-0.01-0.01-0.01-
Price to Earnings Ratio-19.36--19.36--96.49--56.47--4.84-
Price-to-Total Gains Ratio2.47-2.47--9.91--30.20-66.83-
Price to Book Ratio2.53-2.53--61.75--2.70-9.75-
Price-to-Total Gains Ratio2.47-2.47--9.91--30.20-66.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0051776
Number of shares193139
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (193139 shares)1,010.68140.46
Gains per Year (193139 shares)4,042.71561.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10404340330562552
2080858076011241114
301212812119016861676
401617116162022472238
502021420205028092800
602425624248033713362
702829928291039333924
803234232334044954486
903638436377050575048
1004042740420056195610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.07.00.030.0%5.018.01.020.8%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%6.04.00.060.0%13.011.00.054.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.024.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%6.04.00.060.0%13.011.00.054.2%

Fundamentals of Bioxyne

About Bioxyne Ltd

Bioxyne Limited, a life sciences and consumer health products company, manufactures and distributes consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines in the United Kingdom, Japan, Europe, and Australia. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, vitamins, manuka honey, skin care products, and mushroom complexes. It develops various functional food products, such as ingredients; and lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. The company also provides product research and development services, and telemedicine services. In addition, it operates BLS Clinics, a telehealth platform. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-03-29 13:41:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bioxyne Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bioxyne earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • A Net Profit Margin of -37.6% means that $-0.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioxyne Ltd:

  • The MRQ is -37.6%. The company is making a huge loss. -2
  • The TTM is -37.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-37.6%TTM-37.6%0.0%
TTM-37.6%YOY-106.6%+69.0%
TTM-37.6%5Y-49.5%+11.9%
5Y-49.5%10Y-27.9%-21.5%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.6%2.9%-40.5%
TTM-37.6%2.8%-40.4%
YOY-106.6%3.0%-109.6%
5Y-49.5%3.4%-52.9%
10Y-27.9%3.6%-31.5%
1.1.2. Return on Assets

Shows how efficient Bioxyne is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • -11.0% Return on Assets means that Bioxyne generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioxyne Ltd:

  • The MRQ is -11.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.0%TTM-11.0%0.0%
TTM-11.0%YOY-110.9%+99.9%
TTM-11.0%5Y-37.4%+26.4%
5Y-37.4%10Y-12.5%-24.9%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.0%1.5%-12.5%
TTM-11.0%1.5%-12.5%
YOY-110.9%1.5%-112.4%
5Y-37.4%1.5%-38.9%
10Y-12.5%1.8%-14.3%
1.1.3. Return on Equity

Shows how efficient Bioxyne is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • -12.8% Return on Equity means Bioxyne generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioxyne Ltd:

  • The MRQ is -12.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-12.8%0.0%
TTM-12.8%YOY--12.8%
TTM-12.8%5Y-19.9%+7.0%
5Y-19.9%10Y-0.7%-19.2%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%3.2%-16.0%
TTM-12.8%3.0%-15.8%
YOY-3.1%-3.1%
5Y-19.9%3.1%-23.0%
10Y-0.7%3.4%-4.1%

1.2. Operating Efficiency of Bioxyne Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bioxyne is operating .

  • Measures how much profit Bioxyne makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • An Operating Margin of -39.8% means the company generated $-0.40  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioxyne Ltd:

  • The MRQ is -39.8%. The company is operating very inefficient. -2
  • The TTM is -39.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-39.8%TTM-39.8%0.0%
TTM-39.8%YOY-98.0%+58.3%
TTM-39.8%5Y-53.0%+13.2%
5Y-53.0%10Y-30.7%-22.4%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.8%5.0%-44.8%
TTM-39.8%3.6%-43.4%
YOY-98.0%4.9%-102.9%
5Y-53.0%5.2%-58.2%
10Y-30.7%5.1%-35.8%
1.2.2. Operating Ratio

Measures how efficient Bioxyne is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are $1.40 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bioxyne Ltd:

  • The MRQ is 1.398. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.398. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.398TTM1.3980.000
TTM1.398YOY1.980-0.583
TTM1.3985Y1.528-0.131
5Y1.52810Y1.380+0.149
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3981.551-0.153
TTM1.3981.511-0.113
YOY1.9801.453+0.527
5Y1.5281.394+0.134
10Y1.3801.257+0.123

1.3. Liquidity of Bioxyne Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bioxyne is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 2.25 means the company has $2.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioxyne Ltd:

  • The MRQ is 2.248. The company is able to pay all its short-term debts. +1
  • The TTM is 2.248. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.248TTM2.2480.000
TTM2.248YOY0.494+1.754
TTM2.2485Y2.917-0.669
5Y2.91710Y4.009-1.092
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2481.561+0.687
TTM2.2481.606+0.642
YOY0.4941.600-1.106
5Y2.9171.638+1.279
10Y4.0091.650+2.359
1.3.2. Quick Ratio

Measures if Bioxyne is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • A Quick Ratio of 1.80 means the company can pay off $1.80 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioxyne Ltd:

  • The MRQ is 1.802. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.802. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.802TTM1.8020.000
TTM1.802YOY0.392+1.410
TTM1.8025Y2.168-0.366
5Y2.16810Y3.382-1.214
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8020.554+1.248
TTM1.8020.567+1.235
YOY0.3920.608-0.216
5Y2.1680.704+1.464
10Y3.3820.733+2.649

1.4. Solvency of Bioxyne Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bioxyne assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioxyne to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 0.15 means that Bioxyne assets are financed with 15.2% credit (debt) and the remaining percentage (100% - 15.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bioxyne Ltd:

  • The MRQ is 0.152. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.152. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.152TTM0.1520.000
TTM0.152YOY1.829-1.678
TTM0.1525Y0.537-0.385
5Y0.53710Y0.362+0.175
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1520.485-0.333
TTM0.1520.490-0.338
YOY1.8290.481+1.348
5Y0.5370.486+0.051
10Y0.3620.493-0.131
1.4.2. Debt to Equity Ratio

Measures if Bioxyne is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 17.8% means that company has $0.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioxyne Ltd:

  • The MRQ is 0.178. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.178. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.178TTM0.1780.000
TTM0.178YOY-+0.178
TTM0.1785Y0.225-0.048
5Y0.22510Y0.231-0.006
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1780.950-0.772
TTM0.1780.960-0.782
YOY-0.939-0.939
5Y0.2250.997-0.772
10Y0.2311.076-0.845

2. Market Valuation of Bioxyne Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bioxyne generates.

  • Above 15 is considered overpriced but always compare Bioxyne to the Packaged Foods industry mean.
  • A PE ratio of -19.36 means the investor is paying $-19.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioxyne Ltd:

  • The EOD is -7.744. Based on the earnings, the company is expensive. -2
  • The MRQ is -19.361. Based on the earnings, the company is expensive. -2
  • The TTM is -19.361. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.744MRQ-19.361+11.616
MRQ-19.361TTM-19.3610.000
TTM-19.361YOY-96.486+77.126
TTM-19.3615Y-56.472+37.112
5Y-56.47210Y-4.836-51.636
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-7.74413.414-21.158
MRQ-19.36112.772-32.133
TTM-19.36114.017-33.378
YOY-96.48612.714-109.200
5Y-56.47216.330-72.802
10Y-4.83619.121-23.957
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioxyne Ltd:

  • The EOD is -16.943. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -42.357. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -42.357. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.943MRQ-42.357+25.414
MRQ-42.357TTM-42.3570.000
TTM-42.357YOY-40.255-2.102
TTM-42.3575Y786.226-828.583
5Y786.22610Y384.537+401.689
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-16.9433.144-20.087
MRQ-42.3572.852-45.209
TTM-42.3571.711-44.068
YOY-40.2550.425-40.680
5Y786.2261.378+784.848
10Y384.5371.375+383.162
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bioxyne is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 2.53 means the investor is paying $2.53 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioxyne Ltd:

  • The EOD is 1.014. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.534. Based on the equity, the company is underpriced. +1
  • The TTM is 2.534. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.014MRQ2.534-1.521
MRQ2.534TTM2.5340.000
TTM2.534YOY-61.748+64.282
TTM2.5345Y-2.699+5.234
5Y-2.69910Y9.749-12.449
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD1.0141.464-0.450
MRQ2.5341.462+1.072
TTM2.5341.462+1.072
YOY-61.7481.760-63.508
5Y-2.6991.856-4.555
10Y9.7492.419+7.330
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bioxyne Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bioxyne Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0080.0080%-0.001+115%0.001+620%0.001+910%
Book Value Per Share--0.0080.0080%0.000+102%0.002+236%0.002+333%
Current Ratio--2.2482.2480%0.494+355%2.917-23%4.009-44%
Debt To Asset Ratio--0.1520.1520%1.829-92%0.537-72%0.362-58%
Debt To Equity Ratio--0.1780.1780%-+100%0.225-21%0.231-23%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.0010%0.000-88%0.000-54%0.000-74%
Free Cash Flow Per Share--0.0000.0000%0.000-37%0.000-37%0.000-50%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000+250%0.000+727%0.000-58%
Gross Profit Margin--1.3421.3420%1.119+20%1.310+2%1.108+21%
Intrinsic Value_10Y_max--0.003--------
Intrinsic Value_10Y_min---0.008--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.000--------
Intrinsic Value_3Y_min---0.002--------
Intrinsic Value_5Y_max--0.001--------
Intrinsic Value_5Y_min---0.003--------
Market Cap15213200.384-150%38033000.96038033000.9600%22819800.576+67%33469040.845+14%39934651.008-5%
Net Profit Margin---0.376-0.3760%-1.066+183%-0.495+32%-0.279-26%
Operating Margin---0.398-0.3980%-0.980+146%-0.530+33%-0.307-23%
Operating Ratio--1.3981.3980%1.980-29%1.528-9%1.380+1%
Pb Ratio1.014-150%2.5342.5340%-61.748+2536%-2.699+207%9.749-74%
Pe Ratio-7.744+60%-19.361-19.3610%-96.486+398%-56.472+192%-4.836-75%
Price Per Share0.008-150%0.0200.0200%0.012+67%0.018+14%0.021-5%
Price To Free Cash Flow Ratio-16.943+60%-42.357-42.3570%-40.255-5%786.226-105%384.537-111%
Price To Total Gains Ratio0.989-150%2.4742.4740%-9.907+501%-30.196+1321%66.830-96%
Quick Ratio--1.8021.8020%0.392+360%2.168-17%3.382-47%
Return On Assets---0.110-0.1100%-1.109+911%-0.374+241%-0.125+14%
Return On Equity---0.128-0.1280%--100%-0.199+55%-0.007-95%
Total Gains Per Share--0.0080.0080%-0.001+115%0.001+620%0.001+910%
Usd Book Value--9711970.5729711970.5720%-239181.821+102%2889322.013+236%2244539.564+333%
Usd Book Value Change Per Share--0.0050.0050%-0.001+115%0.001+620%0.001+910%
Usd Book Value Per Share--0.0050.0050%0.000+102%0.002+236%0.001+333%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.0010%0.000-88%0.000-54%0.000-74%
Usd Free Cash Flow---581135.118-581135.1180%-366884.089-37%-366631.810-37%-291132.176-50%
Usd Free Cash Flow Per Share--0.0000.0000%0.000-37%0.000-37%0.000-50%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000+250%0.000+727%0.000-58%
Usd Market Cap9845983.289-150%24614958.22124614958.2210%14768974.933+67%21661163.235+14%25845706.132-5%
Usd Price Per Share0.005-150%0.0130.0130%0.008+67%0.011+14%0.014-5%
Usd Profit---1255548.584-1255548.5840%-319731.038-75%-603540.535-52%-331663.141-74%
Usd Revenue--3339900.1943339900.1940%300065.219+1013%1569643.546+113%1399677.500+139%
Usd Total Gains Per Share--0.0050.0050%-0.001+115%0.001+620%0.001+910%
 EOD+2 -6MRQTTM+0 -0YOY+23 -115Y+23 -1110Y+16 -18

4.2. Fundamental Score

Let's check the fundamental score of Bioxyne Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.744
Price to Book Ratio (EOD)Between0-11.014
Net Profit Margin (MRQ)Greater than0-0.376
Operating Margin (MRQ)Greater than0-0.398
Quick Ratio (MRQ)Greater than11.802
Current Ratio (MRQ)Greater than12.248
Debt to Asset Ratio (MRQ)Less than10.152
Debt to Equity Ratio (MRQ)Less than10.178
Return on Equity (MRQ)Greater than0.15-0.128
Return on Assets (MRQ)Greater than0.05-0.110
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Bioxyne Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.799
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.011
OpenGreater thanClose0.008
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets17,693
Total Liabilities2,687
Total Stockholder Equity15,137
 As reported
Total Liabilities 2,687
Total Stockholder Equity+ 15,137
Total Assets = 17,693

Assets

Total Assets17,693
Total Current Assets6,040
Long-term Assets11,653
Total Current Assets
Cash And Cash Equivalents 3,846
Net Receivables 996
Inventory 995
Other Current Assets 203
Total Current Assets  (as reported)6,040
Total Current Assets  (calculated)6,040
+/-0
Long-term Assets
Property Plant Equipment 85
Goodwill 11,568
Intangible Assets 11,568
Long-term Assets Other -11,653
Long-term Assets  (as reported)11,653
Long-term Assets  (calculated)11,568
+/- 85

Liabilities & Shareholders' Equity

Total Current Liabilities2,687
Long-term Liabilities0
Total Stockholder Equity15,137
Total Current Liabilities
Accounts payable 1,205
Other Current Liabilities 1,482
Total Current Liabilities  (as reported)2,687
Total Current Liabilities  (calculated)2,687
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock17,548
Retained Earnings -2,484
Accumulated Other Comprehensive Income 73
Total Stockholder Equity (as reported)15,137
Total Stockholder Equity (calculated)15,137
+/-0
Other
Capital Stock17,548
Cash and Short Term Investments 3,846
Common Stock Shares Outstanding 1,344,132
Liabilities and Stockholders Equity 17,693
Net Debt -3,846
Net Invested Capital 15,137
Net Tangible Assets 3,569
Net Working Capital 3,353
Property Plant and Equipment Gross 210



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
12,543
9,564
4,898
1,980
2,379
1,301
1,073
610
482
486
299
221
6,910
702
1,499
1,513
2,010
4,740
5,050
3,971
3,335
2,679
446
17,693
17,6934462,6793,3353,9715,0504,7402,0101,5131,4997026,9102212994864826101,0731,3012,3791,9804,8989,56412,543
   > Total Current Assets 
12,502
9,370
4,688
1,814
2,220
1,172
995
552
466
479
294
218
2,472
701
1,174
1,188
1,685
4,514
4,735
3,519
3,070
2,510
403
6,040
6,0404032,5103,0703,5194,7354,5141,6851,1881,1747012,4722182944794665529951,1722,2201,8144,6889,37012,502
       Cash And Cash Equivalents 
12,498
259
963
1,470
1,074
403
209
299
197
86
238
112
780
211
992
958
1,354
3,876
3,310
1,768
1,748
1,602
66
3,846
3,846661,6021,7481,7683,3103,8761,354958992211780112238861972992094031,0741,47096325912,498
       Short-term Investments 
0
0
0
120
805
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000805120000
       Net Receivables 
4
9,105
3,633
213
618
381
679
91
244
393
56
106
162
107
121
172
223
227
535
795
353
382
253
996
99625338235379553522722317212110716210656393244916793816182133,6339,1054
       Inventory 
0
0
0
72
440
364
92
158
25
0
0
0
0
0
0
0
0
101
629
714
768
370
76
995
9957637076871462910100000000251589236444072000
   > Long-term Assets 
41
194
209
166
159
129
79
58
16
7
4
3
4,438
1
325
325
325
226
316
452
265
168
43
11,653
11,6534316826545231622632532532514,43834716587912915916620919441
       Property Plant Equipment 
39
192
209
166
159
129
79
58
16
7
4
3
3
1
0
0
325
3
161
209
235
138
43
85
85431382352091613325001334716587912915916620919239
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
50
151
0
0
11,568
11,568
11,56811,56800151505000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
325
325
325
0
0
0
0
0
0
0
000000032532532500000000000000
       Intangible Assets 
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173
105
92
30
30
30
11,568
11,5683030309210517300000000000000022
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
4,435
0
0
0
0
173
105
62
0
0
0
0
00006210517300004,435000000000000
> Total Liabilities 
112
539
640
1,013
1,203
1,114
663
391
1,106
442
175
96
1,022
913
427
229
458
610
729
829
726
745
815
2,687
2,6878157457268297296104582294279131,022961754421,1063916631,1141,2031,013640539112
   > Total Current Liabilities 
112
539
640
1,013
1,192
1,107
659
388
1,106
442
175
96
1,022
913
427
229
458
610
729
829
726
745
815
2,687
2,6878157457268297296104582294279131,022961754421,1063886591,1071,1921,013640539112
       Short-term Debt 
0
0
0
0
0
0
0
0
500
50
50
0
0
0
0
0
0
0
0
47
47
47
0
0
0047474700000000505050000000000
       Accounts payable 
112
466
508
887
769
874
551
261
394
274
55
14
638
380
238
131
215
335
417
433
220
176
204
1,205
1,2052041762204334173352151312383806381455274394261551874769887508466112
       Other Current Liabilities 
0
73
132
126
423
233
108
127
212
118
70
82
384
533
189
99
243
274
312
396
458
569
611
1,482
1,482611569458396312274243991895333848270118212127108233423126132730
   > Long-term Liabilities 
0
0
0
0
11
8
3
3
0
0
0
0
0
0
0
0
0
0
0
433
706
176
95
0
09517670643300000000000338110000
       Other Liabilities 
0
0
0
0
11
8
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5
0
0-500000000000000338110000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173
105
62
0
0
0
0
00006210517300000000000000000
> Total Stockholder Equity
12,431
9,025
4,258
968
1,175
187
411
219
-623
43
123
124
5,888
-211
1,072
1,284
1,551
4,131
4,322
3,089
2,556
1,881
-365
15,137
15,137-3651,8812,5563,0894,3224,1311,5511,2841,072-2115,88812412343-6232194111871,1759684,2589,02512,431
   Common Stock
13,858
13,560
13,597
15,411
19,956
22,900
24,990
26,444
26,934
27,761
27,761
27,761
28,034
28,127
57,427
57,427
57,478
60,816
62,178
62,178
62,178
62,178
129
17,548
17,54812962,17862,17862,17862,17860,81657,47857,42757,42728,12728,03427,76127,76127,76126,93426,44424,99022,90019,95615,41113,59713,56013,858
   Retained Earnings -2,484-544-60,241-59,745-59,372-58,006-56,696-55,930-56,154-56,478-28,978-22,898-27,926-27,927-28,007-27,797-26,465-24,702-22,714-18,780-14,443-9,339-4,535-1,426
   Accumulated Other Comprehensive Income 
-1
-13
-83
-137
-147
-157
123
240
240
289
289
289
751
640
123
11
3
11
150
283
124
-56
50
73
7350-5612428315011311123640751289289289240240123-157-147-137-83-13-1
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
1
13
83
0
0
0
0
0
0
0
0
0
0
0
123
11
3
11
150
108
-2,432
-1,937
188
-15,064
-15,064188-1,937-2,432108150113111230000000000083131



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.